Foresight Diagnostics Inc. vs Personalis, Inc.

Termination Decision: Post-DI Settlement

Joint Motion to Terminate Pursuant to 35 U.S.C. § 317 and 37 C.F.R. § 42.74

EX2022

Joint Request to File Settlement Agreement as Business Confidential and to Keep it Separate From the Patent Files Pursuant to 35 U.S.C. § 317 and 37 C.F.R. § 42.74

Patent Owner’s Updated Exhibit List

Other: Hearing transcript

Order: Granting PHV Motion

Petitioner's Updated Mandatory Notice

Petitioner's Updated Exhibit List

EX1085 Petitioner's Oral Hearing Demonstratives

Patent Owner’s Oral Argument Presentation

Petitioner's Motion to PHV Admission of Alan J. Heinrich

EX1084 Declaration of Alan J. Heinrich ISO of PHV Admission

Patent Owner's Sur-reply to Petitioner's Reply to Patent Owner's Response

Order: Setting Oral Argument 37 C.F.R. sec. 42.70

Patent Owner's Request for Oral Argument

Petitioner's Request for Oral Argument

Joint Stipulation to Modify Due Date 3

Petitioner's Reply to Patent Owner's Response

EX1078 HenryMorriceFurneauxVolI_PDFTran

EX1079 POPR 394

EX1080 NeogenomicsPetition

EX1081 US11384394

EX1082 Lennon Declaration PTAB-IPR2024-00346-1002

EX1083 Furneaux Depo 394 IPR

Joint Stipulation to Modify Due Dates 2 and 3

Petitioner's Amended Notice of Deposition of Dr. Henry Morrice Furneaux

Petitioner's Updated Mandatory Notice

Petitioner's Notice of Deposition of Dr. Henry Morrice Furneaux

Patent Owner Response

EX2010

EX2035

EX2151

EX2153

EX2154

EX2156

EX2163

EX2164

EX2165

EX2166

EX2167

EX2168

EX2169

EX2170

EX2172

EX2177

Joint Stipulation to Modify Due Dates 1-3

Notice of Deposition of Dr. John Quackenbush

Patent Owner's Updated Mandatory Notice

Patent Owner's Power of Attorney

Exhibit 3002

Institution Decision

Scheduling Order

Sur-reply to Petition for Inter Partes Review of U.S. Patent No. 11,299,783

Petitioner's Reply to Patent Owner's Preliminary Response

Exhibit 3001

Preliminary Response to Petition for Inter Partes Review of U.S. Patent No. 11,299,783

The Scientist Staff, “2022 Top 10 Innovations,”

Swanton, C., “Plasma-Derived Tumor DNA Analysis at Whole- Genome Resolution,”

Claim Chart for U.S. Patent No. 11,299,783

Personalis, Inc.'s Updated Mandatory Notice

Notice : Personalis, Inc.'s Mandatory Notice

Notice : Personalis Inc.'s Power of Attorney

Notice: acceptance corrected petition

Petitioner's Notice of Filing Corrected Exhibit List

Petitioner's Corrected Exhibit List

Notice: defective petition

EX1001 US11299783 West

EX1002 Leary, Development of Personalized Tumor Biomarkers

EX1003 Quake WO 2011-057061

EX1004 Anderson, Next Generation DNA Sequencing

EX1005 Gnirke Solution hybrid selection with ultra-long oligonucleotides

EX1006 Mertes, Targeted enrichment of Genomic DNA regions

EX1007 Mamanova, Target-enrichment strategies for next-generation sequencin

EX1008 Chan, Cancer Genome Scanning in Plasma

EX1009 Liao, Targeted Massively Parallel Sequencing

EX1010 Personalis Complaint 2022.08.02 #001-00

EX1012 Ley, DNA sequencing of a cytogenetically normal acute myeloid leukae

EX1013 Shendure, Next-generation DNA sequencing

EX1014 Ross, Whole Cancer Genome Sequencing by Next-Generation Methods

EX1015 McBride, Use of Cancer-Specific Genomic Rearrangements to Quantify D

EX1016 Kurtz, Enhanced detection of minimal residual disease

EX1017 Lo, Cancer Genome Scanning in Plasma

EX1018 Sequencing Cost Data Table, Aug 2021

EX1019 DNA Sequencing Costs Data

EX1023 Quackenbush CV

EX1024 Types of variants, Garvan Institute of Medical Research

EX1025 Oh, Improved DNA Extraction Method for Molecular Diagnosis

EX1026 NIHMS192215 Supplement-S1

EX1027 Lam 2012

EX1028 Technical coverage calculation

EX1029 Illumina, HiSeq 2000 Sequencing System

EX1030 Forshew, Noninvasive Identification and Monitoring of Cancer Mutatio

EX1031 Meyerson, Advances in understanding cancer genomes

EX1040 Sims, Sequencing depth and coverage

EX1041 Li, Mapping short DNA sequencing reads

EX1042 Ley Suppl. Info

EX1043 Newman, Integrated digital error suppression

EX1044 Newman, Ultrasenstive method for quantitating circulating tumor DNA

EX1045 Newman Suppl. Spreadsheet

EX1046 Clark, Performance comparison of exome DNA sequencing

EX1047 Illumina MiSeq Worksheet

EX1048 CDH24

EX1049 SLC15A1

EX1050 KNDC1

EX1051 PTPRT

EX1052 GRINL1B

EX1053 GPR123

EX1054 EBI2

EX1055 PCLKC

EX1056 FLT3

EX1057 NPM1

EX1058 BRCA2

EX1059 TP53

EX1070 Dawson, Analysis of Circulating Tumor DNA

EX1071 Burrell, Causes & Consequences of Genetic Heterogeneity

EX1072 App B '783 Claim Chart

EX1073 Haferlach, Mutations of TP53 gene

EX1074 Misawa, Significance of chromosomal alterations & mutations

EX1075 Davies, Acute Leukemia

EX1076 Alter, Clinical & molecular features

EX1077 Bentley, Accurate whole human genome sequencing

Petition : as filed

EX1020 783 Quackenbush Declaration

Notice : Power of Attorney